ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC.

Saved in:
Bibliographic Details
Title: ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC.
Authors: Christyani G; Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan, Chungcheongnam-do, Republic of Korea., Cai C; College of Biology, Hunan University, Changsha, China., Feng Y; Department of Oncology, Mayo Clinic, Rochester, MN, United States., Lee H; Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan, Chungcheongnam-do, Republic of Korea., Tu X; Department of Oncology, Mayo Clinic, Rochester, MN, United States., Zhang C; Department of Oncology, Mayo Clinic, Rochester, MN, United States., Lou Z; Department of Oncology, Mayo Clinic, Rochester, MN, United States., Kim W; Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan, Chungcheongnam-do, Republic of Korea.
Source: Frontiers in oncology [Front Oncol] 2026 Feb 18; Vol. 15, pp. 1680561. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1680561